🔎 Trials Near Me

Domov › Obézita › Texas › Dallas

Klinické štúdie Obézita v meste Dallas, TX

30 štúdií pre Obézita hľadá účastníkov v zariadeniach v meste Dallas a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Prebieha náborFáza 2
  • Velocity Clinical Research - Dallas /ID# 282734, Dallas
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07752979

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Prebieha nábor
  • Baylor Scott & White Institute for Research, Dallas
Vek 18 až 70 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06003686

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Prebieha náborFáza 3
  • UT Southwestern Med Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Prebieha náborFáza 3
  • North Texas Endocrine Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Prebieha náborFáza 3
  • UT Southwestern Med Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Prebieha náborFáza 3
  • Velocity Clinical Res-Dallas, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Prebieha náborFáza 3
  • Velocity Clinical Research, Dallas, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Prebieha náborFáza 3
  • UT Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Prebieha náborFáza 3
  • Thyroid Endocrinology and Diabetes, Dallas
  • Soltero Cardiovascular Research Center, Dallas
  • Zenos Clinical Research, Dallas
  • a 2 ďalších
Vek 45 až 99 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Prebieha náborFáza 3
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Prebieha náborFáza 2
  • FutureSearch Trials of Dallas, Dallas
Vek 18 až 75 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07589608

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Prebieha náborFáza 3
  • Cedar Health Research, LLC, Dallas
Vek 18 až 99 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Prebieha náborFáza 3
  • Velocity Clinical Research, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Prebieha náborFáza 3
  • University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Prebieha náborFáza 3
  • Cedar Health Research, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Prebieha náborFáza 2
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Prebieha náborFáza 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Prebieha náborFáza 3
  • Cedar Health Research, LLC, Dallas
Vek 18 až 99 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07684235

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Prebieha náborSkorá fáza 1Vítaní zdravých dobrovoľníkov
  • University of Texas Southwestern Medical Center, Dallas
Vek 18 až 55 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT04838678

Effects of Obesity in the Aged

Prebieha náborVítaní zdravých dobrovoľníkov
  • Institute for Exercise and Environmental Medicine, UT Southwestern and Texas Health Resources, Dallas
Vek 65 až 75 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05028309

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Prebieha náborFáza 2
  • University of Texas, Southwestern, Dallas
Vek 7 až 25 · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Prebieha náborFáza 3
  • Renal Disease Research Institute, Dallas
  • Texas Health Heart and Vascular Specialists, Dallas
  • Southwest Family Medicine_Dallas, Dallas
  • a 1 ďalších
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Prebieha náborFáza 3
  • Mercy Family Clinic, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT07509307

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Prebieha náborFáza 2
  • Velocity Clinical Research Dallas, Dallas
Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT07477704

UTSW NORC Pilot Spinal Cord Injury Dietary Program

Prebieha nábor
  • University of Texas Southwestern Medical Center, Dallas
Vek 18 až 65 · Všetky pohlavia · Aktualizované 15. 7. 2026 · NCT06924177

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

Prebieha náborVítaní zdravých dobrovoľníkov
  • UT Southwestern Medical Center, Dallas
Vek 55 až 90 · Všetky pohlavia · Aktualizované 7. 5. 2026 · NCT05723679

Leg Heating in Pregnant Women With Obesity

Prebieha náborVítaní zdravých dobrovoľníkov
  • UT Southwestern Medical Center; Institute for Exercise and Environmental Medicine, Dallas
Vek 18 až 45 · Ženy · Aktualizované 17. 4. 2026 · NCT06932250

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

Prebieha nábor
  • University of Texas Southwestern, Children's Health, Dallas
Vek 6 až 14 · Všetky pohlavia · Aktualizované 30. 3. 2026 · NCT07342855

Healthy Living BEYOND Weight Study

Prebieha náborObservačná štúdia
  • American Heart Association, Dallas
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 8. 2025 · NCT07075341

Štúdie Obézita v iných mestách

Iné štúdie v Dallas

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.